// App-Quantinova.ai

TCT-198 : Six Years Consecutive Complete Follow-up Result of Sirolimus Eluting Stent (SES) Implanted Lesion.

Researchers

Presenter

  • Yohei Inoue

Principal Investigators

  • Yoshisato Shibata

Medical Centers

  • Miyazaki medical association hospital, Miyazaki, Miyazaki, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim